Identification and characterization of eukaryotic initiation factor 5A-2

被引:104
作者
Clement, PMJ
Henderson, CA
Jenkins, ZA
Smit-McBride, Z
Wolff, EC
Hershey, JWB
Park, MH
Johansson, HE
机构
[1] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
[2] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA
[3] Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA
[4] Univ Uppsala, Dept Cell & Mol Biol, S-75105 Uppsala, Sweden
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2003年 / 270卷 / 21期
关键词
deoxyhypusine; eIF5A; eIF5A-2; hypusine; polyamines; post-translational modification;
D O I
10.1046/j.1432-1033.2003.03806.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The phylogenetically conserved eukaryotic translation initiation factor 5A(eIF5A) is the only known cellular protein to contain the post-translationally derived amino acid hypusine [N-epsilon-(4-amino-2-hydroxybutyl)lysine]. Both eIF5A and its hypusine modi. cation are essential for sustained cell proliferation. Normally only one eIF5A protein is expressed in human cells. Recently, we identified a second human EIF5A gene that would encode an isoform (eIF5A-2) of 84% sequence identity. Overexpression of eIF5A-2 mRNA in certain human cancer cells, in contrast to weak normal expression limited to human testis and brain, suggests EIF5A2 as a potential oncogene. However, eIF5A-2 protein has not been described in human or mammalian cells heretofore. Here, we describe the identification of eIF5A-2 protein in human colorectal and ovarian cancer lines, SW-480 and UACC-1598, that overexpress eIF5A-2 mRNAs. Functional characterization of the human isoforms revealed that either human EIF5A gene can complement growth of a yeast strain in which the yeast EIF5A genes were disrupted. This indicates functional similarity of the human isoforms in yeast and suggests that eIF5A-2 has an important role in eukaryotic cell survival similar to that of the ubiquitous eIF5A-1. Detectable structural differences were also noted, including lack of immunological cross-reactivity, formation of different complexes with deoxyhypusine synthase, and K-m values (1.5 +/- 0.2 vs. 8.3 +/- 1.4 muM for eIF5A-1 and -2, respectively) as substrates for deoxyhypusine synthase in vitro. These physical characteristics and distinct amino acid sequences in the C- terminal domain together with differences in gene expression patterns imply differentiated, tissue-specific functions of the eIF5A-2 isoform in the mammalian organism and in cancer.
引用
收藏
页码:4254 / 4263
页数:10
相关论文
共 61 条
[11]   Effects of inhibitors of deoxyhypusine synthase on the differentiation of mouse neuroblastoma and erythroleukemia cells [J].
Chen, ZP ;
Yan, YP ;
Ding, QJ ;
Knapp, S ;
Potenza, JA ;
Schugar, HJ ;
Chen, KY .
CANCER LETTERS, 1996, 105 (02) :233-239
[12]   The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro [J].
Clement, PMJ ;
Hanauske-Abel, HM ;
Wolff, EC ;
Kleinman, HK ;
Park, MH .
INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (04) :491-498
[13]   Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion [J].
Coller, HA ;
Grandori, C ;
Tamayo, P ;
Colbert, T ;
Lander, ES ;
Eisenman, RN ;
Golub, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3260-3265
[14]   2 HYPUSINE-CONTAINING PROTEINS IDENTIFIED BY METABOLIC LABELING IN CHICK-EMBRYO FIBROBLASTS [J].
DOU, QP ;
CHEN, KY .
JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 1989, 36 (05) :443-450
[15]  
Dua K, 2001, PROTEOMICS, V1, P1191, DOI 10.1002/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO
[16]  
2-8
[17]  
DUNCAN RF, 1986, J BIOL CHEM, V261, P2903
[18]  
Guan XY, 2001, CANCER RES, V61, P3806
[19]   INHIBITION OF THE G1-S TRANSITION OF THE CELL-CYCLE BY INHIBITORS OF DEOXYHYPUSINE HYDROXYLATION [J].
HANAUSKEABEL, HM ;
PARK, MH ;
HANAUSKE, AR ;
POPOWICZ, AM ;
LALANDE, M ;
FOLK, JE .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1221 (02) :115-124
[20]  
HERSHEY JWB, 2000, TRANSLATIONAL CONTRO, P627